Insider Transactions in Q2 2024 at Krystal Biotech, Inc. (KRYS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
Jun 11
2024
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.2%
|
$4,375,000
$175.06 P/Share
|
|
Jun 11
2024
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.2%
|
$4,350,000
$174.85 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
SELL
Open market or private sale
|
Direct |
20,000
-77.61%
|
$3,280,000
$164.6 P/Share
|
|
May 20
2024
|
Julian S Gangolli Director |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+50.0%
|
$440,000
$22.75 P/Share
|